Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (251-260 of 297) with videos related to

Pageof 30
Sort By:
Neuropsychiatric Disease and Treatment|April 27, 2012
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophreniaNaoki Goto, Reiji Yoshimura, Shingo Kakeda, et al.
Psychiatry Research|June 17, 2015
Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRISatoru Ide, Shingo Kakeda, Keita Watanabe, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 20, 2016
Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statisticsXiaodan Liu, Keita Watanabe, Shingo Kakeda, et al.
Biomedical Chromatography : BMC|January 16, 2013
Determination of paroxetine in serum treated with simple pretreatment by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagentHirofumi Inoue, Takuya Harada, Seiji Eto, et al.
Rheumatology (Oxford, England)|February 28, 2023
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosusYuya Fujita, Shigeru Iwata, Shinsuke Hidese, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Implementations of an evidence-based assertive case management intervention for suicide attempters: Post-ACTION-J Study (PACS)Takao Ishii, Naohiro Yonemoto, Yasushi Otaka, et al.
Therapeutic Advances in Psychopharmacology|January 20, 2017
The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scaleHikaru Hori, Nobuhisa Ueda, Hideki Shiozuka, et al.
Psychiatry and Clinical Neurosciences|November 18, 2006
Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics studyReiji Yoshimura, Tatsuya Okamoto, Jun Nakamura, et al.
Psychiatry Research|January 28, 2014
No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophreniaTaro Kishi, Yasuhisa Fukuo, Masatsugu Moriwaki, et al.
Depression and Anxiety|August 21, 2015
RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDYXiaodan Liu, Shingo Kakeda, Keita Watanabe, et al.
Pageof 30

Showing results (251-260 of 297) with videos related to

Sort By:
Pageof 30
Neuropsychiatric Disease and Treatment|April 27, 2012
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophreniaNaoki Goto, Reiji Yoshimura, Shingo Kakeda, et al.
Psychiatry Research|June 17, 2015
Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRISatoru Ide, Shingo Kakeda, Keita Watanabe, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 20, 2016
Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statisticsXiaodan Liu, Keita Watanabe, Shingo Kakeda, et al.
Biomedical Chromatography : BMC|January 16, 2013
Determination of paroxetine in serum treated with simple pretreatment by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagentHirofumi Inoue, Takuya Harada, Seiji Eto, et al.
Rheumatology (Oxford, England)|February 28, 2023
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosusYuya Fujita, Shigeru Iwata, Shinsuke Hidese, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Implementations of an evidence-based assertive case management intervention for suicide attempters: Post-ACTION-J Study (PACS)Takao Ishii, Naohiro Yonemoto, Yasushi Otaka, et al.
Therapeutic Advances in Psychopharmacology|January 20, 2017
The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scaleHikaru Hori, Nobuhisa Ueda, Hideki Shiozuka, et al.
Psychiatry and Clinical Neurosciences|November 18, 2006
Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics studyReiji Yoshimura, Tatsuya Okamoto, Jun Nakamura, et al.
Psychiatry Research|January 28, 2014
No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophreniaTaro Kishi, Yasuhisa Fukuo, Masatsugu Moriwaki, et al.
Depression and Anxiety|August 21, 2015
RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDYXiaodan Liu, Shingo Kakeda, Keita Watanabe, et al.
Pageof 30